Cargando…

Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

Detalles Bibliográficos
Autores principales: Liu, Yang, Lu, Li-Li, Wen, Duo, Liu, Dong-Li, Dong, Li-Li, Gao, Dong-Mei, Bian, Xin-Yu, Zhou, Jian, Fan, Jia, Wu, Wei-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199356/
https://www.ncbi.nlm.nih.gov/pubmed/32366313
http://dx.doi.org/10.1186/s13045-020-00875-5
_version_ 1783529142162030592
author Liu, Yang
Lu, Li-Li
Wen, Duo
Liu, Dong-Li
Dong, Li-Li
Gao, Dong-Mei
Bian, Xin-Yu
Zhou, Jian
Fan, Jia
Wu, Wei-Zhong
author_facet Liu, Yang
Lu, Li-Li
Wen, Duo
Liu, Dong-Li
Dong, Li-Li
Gao, Dong-Mei
Bian, Xin-Yu
Zhou, Jian
Fan, Jia
Wu, Wei-Zhong
author_sort Liu, Yang
collection PubMed
description
format Online
Article
Text
id pubmed-7199356
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71993562020-05-08 Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming Liu, Yang Lu, Li-Li Wen, Duo Liu, Dong-Li Dong, Li-Li Gao, Dong-Mei Bian, Xin-Yu Zhou, Jian Fan, Jia Wu, Wei-Zhong J Hematol Oncol Correction BioMed Central 2020-05-04 /pmc/articles/PMC7199356/ /pubmed/32366313 http://dx.doi.org/10.1186/s13045-020-00875-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Liu, Yang
Lu, Li-Li
Wen, Duo
Liu, Dong-Li
Dong, Li-Li
Gao, Dong-Mei
Bian, Xin-Yu
Zhou, Jian
Fan, Jia
Wu, Wei-Zhong
Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title_full Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title_fullStr Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title_full_unstemmed Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title_short Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
title_sort correction to: mir-612 regulates invadopodia of hepatocellular carcinoma by hadha-mediated lipid reprogramming
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199356/
https://www.ncbi.nlm.nih.gov/pubmed/32366313
http://dx.doi.org/10.1186/s13045-020-00875-5
work_keys_str_mv AT liuyang correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT lulili correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT wenduo correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT liudongli correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT donglili correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT gaodongmei correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT bianxinyu correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT zhoujian correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT fanjia correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming
AT wuweizhong correctiontomir612regulatesinvadopodiaofhepatocellularcarcinomabyhadhamediatedlipidreprogramming